Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

18 févr. 2025 21h17 HE | Source: Robbins LLP

BIOA STOCK NEWS: Robbins LLP Reminds BioAge Labs, Inc. Investors of the Pending Lead Plaintiff Deadline – March 10, 2025

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
17 janv. 2025 17h29 HE | Source: Robbins LLP

BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the BIOA Class Action

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
13 janv. 2025 20h39 HE | Source: Robbins LLP

BIOA Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against BioAge Labs, Inc.

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
08 janv. 2025 18h46 HE | Source: Robbins LLP

Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO